Comparison of the Effectiveness of Conventional Treatment and Patient Education in Addition to Conventional Treatment in Individuals With Chronic Non-specific Low Back Pain
Launched by KIRSEHIR AHI EVRAN UNIVERSITESI · Jun 4, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Low back pain is a common musculoskeletal disorder that affects approximately 80% of adults. Low back pain causes disability and functional impairment and places a significant burden on national health expenditures. Factors such as trauma, high body mass index, heavy working conditions, and weak abdominal and back muscles can cause low back pain. The most common cause of lower back pain is regional mechanical dysfunction. Rather than a single acute trauma, repetitive, cumulative traumas over time play a significant role. Risk factors such as heavy living and working conditions, poor static ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with chronic low back pain by a specialist physician
- • Patients who have had low back pain for more than six months
- • Patients aged 18 years or older and between 18 and 65 years of age
- • Patients who are not currently receiving any treatment for low back pain
- • Patients with chronic non-specific low back pain
- Exclusion Criteria:
- • Patients with a history of surgery or trauma involving the lumbar or thoracic region,
- • Patients who have received treatment for back pain in the past year,
- • Patients with disc pathology, spinal fracture or dislocation, infection, malignancy, previous surgery, metabolic or inflammatory back pain, and neurological loss
- • Patients who refuse to participate in the study or who do not sign the informed consent form
About Kirsehir Ahi Evran Universitesi
Kırşehir Ahi Evran University is a distinguished academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in various healthcare fields to facilitate innovative research initiatives aimed at improving patient outcomes and advancing scientific knowledge. With a focus on collaboration and ethical standards, Kırşehir Ahi Evran University actively engages in clinical trials that encompass a broad spectrum of medical disciplines, fostering an environment that encourages rigorous scientific inquiry and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kirsehir, , Turkey
Kirsehir, Kırşehir, Turkey
Patients applied
Trial Officials
Mehmet CANLI, PhD.
Study Director
Kirsehir Ahi Evran Universitesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported